Tag: Parkinson’s disease biomarkers

A new study is bringing molecular precision to one of Parkinson’s disease’s most important biological puzzles: why changes in the ...

A team of researchers reports that oligomeric alpha-synuclein carried inside neural-derived extracellular vesicles (NDEVs) may forecast specific non-motor burdens in ...

A new viral-science headline from 2026 spotlights an emerging lipid signal in Parkinson’s disease: plasma ceramide ratios. Researchers report that ...

In a groundbreaking study set to transform the understanding of Parkinson’s disease progression, researchers have identified plasma phosphorylated tau proteins ...

In a groundbreaking development that promises to deepen our understanding of Parkinson’s disease, a collaborative team of neuroscientists has identified ...

In an exciting breakthrough that could pave the way for novel therapeutic strategies in neurodegenerative disorders, researchers Zhang and Wang ...

In the realm of neurodegenerative diseases, the understanding of Lewy body diseases and other alpha-synucleinopathies has rapidly evolved, with significant ...

In a groundbreaking advancement poised to reshape Parkinson’s disease diagnostics, researchers have identified a synergistic blood-based biomarker duo, AP3B1 and ...

In a landmark study poised to recalibrate our understanding of Parkinson’s disease biomarkers, researchers have revealed pivotal insights into the ...

In a groundbreaking study that could fundamentally alter our understanding of neurodegenerative diseases, researchers have probed the effects of sublethal ...